342 related articles for article (PubMed ID: 33129354)
41. Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer.
Martin MC; Zeng G; Yu J; Schiltz GE
J Med Chem; 2020 Dec; 63(24):15344-15370. PubMed ID: 33283516
[TBL] [Abstract][Full Text] [Related]
42. PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma.
Shivram H; Le SV; Iyer VR
PLoS One; 2019; 14(9):e0222435. PubMed ID: 31513636
[TBL] [Abstract][Full Text] [Related]
43. Histone methylation by PRC2 is inhibited by active chromatin marks.
Schmitges FW; Prusty AB; Faty M; Stützer A; Lingaraju GM; Aiwazian J; Sack R; Hess D; Li L; Zhou S; Bunker RD; Wirth U; Bouwmeester T; Bauer A; Ly-Hartig N; Zhao K; Chan H; Gu J; Gut H; Fischle W; Müller J; Thomä NH
Mol Cell; 2011 May; 42(3):330-41. PubMed ID: 21549310
[TBL] [Abstract][Full Text] [Related]
44. Gene repression. H3K27me and PRC2 transmit a memory of repression across generations and during development.
Gaydos LJ; Wang W; Strome S
Science; 2014 Sep; 345(6203):1515-8. PubMed ID: 25237104
[TBL] [Abstract][Full Text] [Related]
45. Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.
Lee CH; Yu JR; Granat J; Saldaña-Meyer R; Andrade J; LeRoy G; Jin Y; Lund P; Stafford JM; Garcia BA; Ueberheide B; Reinberg D
Genes Dev; 2019 Oct; 33(19-20):1428-1440. PubMed ID: 31488577
[TBL] [Abstract][Full Text] [Related]
46. PRC2 mediated H3K27 methylations in cellular identity and cancer.
Conway E; Healy E; Bracken AP
Curr Opin Cell Biol; 2015 Dec; 37():42-8. PubMed ID: 26497635
[TBL] [Abstract][Full Text] [Related]
47. A Functional Link between Nuclear RNA Decay and Transcriptional Control Mediated by the Polycomb Repressive Complex 2.
Garland W; Comet I; Wu M; Radzisheuskaya A; Rib L; Vitting-Seerup K; Lloret-Llinares M; Sandelin A; Helin K; Jensen TH
Cell Rep; 2019 Nov; 29(7):1800-1811.e6. PubMed ID: 31722198
[TBL] [Abstract][Full Text] [Related]
48. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
49. Polycomb Repressive Complex 2 is essential for development and maintenance of a functional TEC compartment.
Singarapu N; Ma K; Reeh KAG; Shen J; Lancaster JN; Yi S; Xie H; Orkin SH; Manley NR; Ehrlich LIR; Jiang N; Richie ER
Sci Rep; 2018 Sep; 8(1):14335. PubMed ID: 30254371
[TBL] [Abstract][Full Text] [Related]
50. The Multiple Facets of PRC2 Alterations in Cancers.
Wassef M; Margueron R
J Mol Biol; 2017 Jun; 429(13):1978-1993. PubMed ID: 27742591
[TBL] [Abstract][Full Text] [Related]
51. Bending and looping of long DNA by Polycomb repressive complex 2 revealed by AFM imaging in liquid.
Heenan PR; Wang X; Gooding AR; Cech TR; Perkins TT
Nucleic Acids Res; 2020 Apr; 48(6):2969-2981. PubMed ID: 32043141
[TBL] [Abstract][Full Text] [Related]
52. Preparation and Characterization of Chromatin Templates for Histone Methylation Assays.
Liu C; Zhao J; Li G
Methods Mol Biol; 2022; 2529():91-107. PubMed ID: 35733011
[TBL] [Abstract][Full Text] [Related]
53. A novel form of JARID2 is required for differentiation in lineage-committed cells.
Al-Raawi D; Jones R; Wijesinghe S; Halsall J; Petric M; Roberts S; Hotchin NA; Kanhere A
EMBO J; 2019 Feb; 38(3):. PubMed ID: 30573669
[TBL] [Abstract][Full Text] [Related]
54. Recruiting polycomb to chromatin.
van Kruijsbergen I; Hontelez S; Veenstra GJ
Int J Biochem Cell Biol; 2015 Oct; 67():177-87. PubMed ID: 25982201
[TBL] [Abstract][Full Text] [Related]
55. The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.
Zhang X; Murray B; Mo G; Shern JF
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182803
[TBL] [Abstract][Full Text] [Related]
56. Histone variants H2A.Z and H3.3 coordinately regulate PRC2-dependent H3K27me3 deposition and gene expression regulation in mES cells.
Wang Y; Long H; Yu J; Dong L; Wassef M; Zhuo B; Li X; Zhao J; Wang M; Liu C; Wen Z; Chang L; Chen P; Wang QF; Xu X; Margueron R; Li G
BMC Biol; 2018 Sep; 16(1):107. PubMed ID: 30249243
[TBL] [Abstract][Full Text] [Related]
57. Conservation and diversification of polycomb repressive complex 2 (PRC2) proteins in the green lineage.
Huang Y; Chen DH; Liu BY; Shen WH; Ruan Y
Brief Funct Genomics; 2017 Mar; 16(2):106-119. PubMed ID: 27032420
[TBL] [Abstract][Full Text] [Related]
58. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins.
Zoabi M; Sadeh R; de Bie P; Marquez VE; Ciechanover A
Biochem Biophys Res Commun; 2011 May; 408(3):393-8. PubMed ID: 21513699
[TBL] [Abstract][Full Text] [Related]
59. Strategy for "detoxification" of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2.
Brown ZZ; Müller MM; Jain SU; Allis CD; Lewis PW; Muir TW
J Am Chem Soc; 2014 Oct; 136(39):13498-501. PubMed ID: 25180930
[TBL] [Abstract][Full Text] [Related]
60. Signaling function of PRC2 is essential for TCR-driven T cell responses.
Dobenecker MW; Park JS; Marcello J; McCabe MT; Gregory R; Knight SD; Rioja I; Bassil AK; Prinjha RK; Tarakhovsky A
J Exp Med; 2018 Apr; 215(4):1101-1113. PubMed ID: 29523590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
